|
Gene expression profiling of T-cell inflammation in small cell lung cancer. |
|
|
Employment - Harbour Cancer Centre |
Leadership - Harbour Cancer Centre |
Stock and Other Ownership Interests - Harbour Cancer Centre |
|
Consulting or Advisory Role - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Viralytics |
|
|
Honoraria - Amgen; AstraZeneca |
Consulting or Advisory Role - Amgen; AstraZeneca |
Patents, Royalties, Other Intellectual Property - Provisional Patent |
Travel, Accommodations, Expenses - Bio-Rad |
|
|
Stock and Other Ownership Interests - RareCyte |
Honoraria - Bluebird Bio; Celgene; Cynata Therapeutics; Genea; GlaxoSmithKline; Novartis; Pfizer; Spark Therapeutics; Takeda |
Consulting or Advisory Role - Imago Pharma; RareCyte |
|
|
No Relationships to Disclose |